APRE Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Aprea Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 5.35 USD -1.83%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast APRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APRE is 15.98 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

APRE Lowest Forecast

Wall Street Target

APRE Average Forecast

Wall Street Target

APRE Highest Forecast

Wall Street Target

108% Upside

199% Upside

293% Upside

The latest public price target was made on Jul 8, 2022 by Robert Driscoll from Wedbush , who expects APRE stock to drop by 44% over the next 12 months. You can read more about this price target by viewing the article on Pulse 2.0.

Analyst	Price Target	Date	Article
Robert Driscoll Wedbush	3 USD Downside 44%	1 year ago Jul 8, 2022	Aprea Therapeutics (APRE) Stock: Why It Jumped Up Over 19% Today Pulse 2.0

Price Target	3 USD
Upside/Downside	44%

Iovance Biotherapeutics Inc

90% Upside

Daan Gene Co Ltd

103% Upside

Dyadic International Inc

435% Upside

OPKO Health Inc

233% Upside

Iovance Biotherapeutics Inc

90% Upside

Daan Gene Co Ltd

103% Upside

Dyadic International Inc

435% Upside

OPKO Health Inc

233% Upside

Eliem Therapeutics Inc

56% Downside

Philogen SpA

34% Upside

Biotest AG

19% Downside

Shanghai OPM Biosciences Co Ltd

32% Upside

Revenue
Forecast

The compound annual growth rate of Aprea Therapeutics Inc's revenue for the next 3 years is -19%.

N/A

-19%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-5%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-71%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for APRE is 15.98 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.

The compound annual growth rate of Aprea Therapeutics Inc's revenue for the next 3 years is -19%.

Join more than 134,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.